Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis

SIMPLE SUMMARY: Lately, a more personalized approach in the management of advanced thyroid cancer patients has improved the outcomes, and several novel molecularly guided therapies, including selective RET inhibitors (sRETis), have demonstrated promising efficacy in clinical trials. RET (rearranged...

Descripción completa

Detalles Bibliográficos
Autores principales: Koehler, Viktoria Florentine, Adam, Pia, Fuss, Carmina Teresa, Jiang, Linmiao, Berg, Elke, Frank-Raue, Karin, Raue, Friedhelm, Hoster, Eva, Knösel, Thomas, Schildhaus, Hans-Ulrich, Negele, Thomas, Siebolts, Udo, Lorenz, Kerstin, Allelein, Stephanie, Schott, Matthias, Spitzweg, Christine, Kroiss, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324961/
https://www.ncbi.nlm.nih.gov/pubmed/35884466
http://dx.doi.org/10.3390/cancers14143405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324961/
https://www.ncbi.nlm.nih.gov/pubmed/35884466
http://dx.doi.org/10.3390/cancers14143405

Ejemplares similares